LiberaBio

www.liberabio.com

LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.

Read more

Reach decision makers at LiberaBio

Lusha Magic

Free credit every month!

LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.

Read more
icon

Country

icon

City (Headquarters)

Santiago de Compostela

icon

Employees

1-10

icon

Founded

2018

icon

Social

  • icon
  • icon

Employees statistics

View all employees

Potential Decision Makers

  • Co - Founder

    Email ****** @****.com
    Phone (***) ****-****
  • Director of Finance and Administration ( Daf )

    Email ****** @****.com
    Phone (***) ****-****
  • Board Observer

    Email ****** @****.com
    Phone (***) ****-****

Reach decision makers at LiberaBio

Free credits every month!

My account

Sign up now to uncover all the contact details